Ad
related to: sigma 5 fluorouracil f6627 equivalent to 1 mm 10- Common Adverse Reactions
Learn About Managing Potential
Adverse Reactions For ENHERTU®.
- Dosing Information
View The Dosing Information
For Using ENHERTU® As A Treatment.
- View The Safety Info
View Safety Info & Possible
Adverse Reactions For ENHERTU®.
- Efficacy Of ENHERTU®
Learn About The Efficacy
Of ENHERTU® For an Indication.
- Physician Resources
Access Physician Resources
For ENHERTU® On The Official Site.
- About ENHERTU®
Discover If ENHERTU® May Be a
Treatment Option For Your Patients.
- Common Adverse Reactions
Search results
Results From The WOW.Com Content Network
Fluorouracil (5-FU, 5-fluorouracil), sold under the brand name Adrucil among others, is a cytotoxic chemotherapy medication used to treat cancer. [3] By intravenous injection it is used for treatment of colorectal cancer , oesophageal cancer , stomach cancer , pancreatic cancer , breast cancer , and cervical cancer . [ 3 ]
Fluorodeoxyuridylate, [1] also known as FdUMP, 5-fluoro-2'-deoxyuridylate, and 5-fluoro-2'-deoxyuridine 5'-monophosphate, is a molecule formed in vivo from 5-fluorouracil and 5-fluorodeoxyuridine. FdUMP acts as a suicide inhibitor of thymidylate synthase (TS). By inhibiting the deoxynucleotide biosynthesis, FdUMP stops the rapidly proliferation ...
Day 1–2: Oxaliplatin 100 mg/m 2 IV infusion, given as a 120 minutes IV infusion in 500 mL D5W, concurrent with leucovorin 400 mg/m 2 (or levoleucovorin 200 mg/m 2) IV infusion, followed by 5-FU 400 mg/m 2 IV bolus, followed by 46-hour 5-FU infusion (2400 mg/m 2 for first two cycles, and may be increased to 3000 mg/m 2 if tolerated by patient ...
1,1-disub. alkenes 1655 medium cis-1,2-disub. alkenes 1660 medium trans-1,2-disub. alkenes 1675 medium trisub., tetrasub. alkenes 1670 weak conjugated C═C dienes 1600 strong 1650 strong with benzene ring 1625 strong with C═O 1600 strong C═C (both sp 2) any 1640–1680 medium aromatic C═C any 1450 weak to strong (usually 3 or 4) 1500 1580
Tegafur is a chemotherapeutic prodrug of 5-fluorouracil (5-FU) used in the treatment of cancers. It is a component of the combination drug tegafur/uracil. When metabolised, it becomes 5-FU. [1] It was patented in 1967 and approved for medical use in 1972. [2]
Floxuridine is rapidly catabolized to 5-fluorouracil, which is the active form of the drug. The primary effect is interference with DNA synthesis and to a lesser extent, inhibition of RNA formation through the drug's incorporation into RNA , thus leading to the production of fraudulent RNA.
5-Fluoroorotic acid (5FOA) is a fluorinated derivative of the pyrimidine precursor orotic acid. It is used in yeast genetics to select for the absence of the URA3 gene, which encodes the enzyme for the decarboxylation of 5-fluoroorotic acid to 5-fluorouracil , a toxic metabolite. [ 1 ]
As fluorouracil, carmofur has been known to induce leukoencephalopathy, characterized by progressive damage to white matter in the brain with stroke-like symptoms. [ 8 ] [ 9 ] [ 10 ] A clinical trial for small hepatocellular carcinoma was stopped prematurely because 56% of the treated patients had unacceptable side effects.